Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01894958Phase 2Completed
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Fragile X Syndrome
Principalinvestigator
NCT01908192Phase 2/3Terminated
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Schizophrenia
Principalinvestigator

Research Network

Collaboration Network

29 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01894958Phase 2PrincipalInvestigator

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Fragile X Syndrome
Completed
NCT01908192Phase 2/3PrincipalInvestigator

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Schizophrenia
Terminated

All 2 trials loaded